Literature DB >> 20048675

The 1918 influenza pandemic: lessons for 2009 and the future.

David M Morens1, Jeffery K Taubenberger, Hillery A Harvey, Matthew J Memoli.   

Abstract

The 1918 to 1919 H1N1 influenza pandemic is among the most deadly events in recorded human history, having killed an estimated 50 to 100 million persons. Recent H5N1 avian influenza epizootics associated with sporadic human fatalities have heightened concern that a new influenza pandemic, one at least as lethal as that of 1918, could be developing. In early 2009, a novel pandemic H1N1 influenza virus appeared, but it has not exhibited unusually high pathogenicity. Nevertheless, because this virus spreads globally, some scientists predict that mutations will increase its lethality. Therefore, to accurately predict, plan, and respond to current and future influenza pandemics, we must first better-understand the events and experiences of 1918. Although the entire genome of the 1918 influenza virus has been sequenced, many questions about the pandemic it caused remain unanswered. In this review, we discuss the origin of the 1918 pandemic influenza virus, the pandemic's unusual epidemiologic features and the causes and demographic patterns of fatality, and how this information should impact our response to the current 2009 H1N1 pandemic and future pandemics. After 92 yrs of research, fundamental questions about influenza pandemics remain unanswered. Thus, we must remain vigilant and use the knowledge we have gained from 1918 and other influenza pandemics to direct targeted research and pandemic influenza preparedness planning, emphasizing prevention, containment, and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20048675      PMCID: PMC3180813          DOI: 10.1097/CCM.0b013e3181ceb25b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  67 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

2.  Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Authors:  Thomas C Luke; Edward M Kilbane; Jeffrey L Jackson; Stephen L Hoffman
Journal:  Ann Intern Med       Date:  2006-08-29       Impact factor: 25.391

3.  Preparing for the next pandemic.

Authors:  Michael T Osterholm
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

4.  SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues.

Authors:  Tracey Baas; Jeffery K Taubenberger; Pek Yoon Chong; Paul Chui; Michael G Katze
Journal:  J Interferon Cytokine Res       Date:  2006-05       Impact factor: 2.607

5.  Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.

Authors:  Yong Jiang; Jun Xu; Chengzhi Zhou; Zhenguo Wu; Shuqing Zhong; Jinghua Liu; Wei Luo; Tao Chen; Qinghe Qin; Peng Deng
Journal:  Am J Respir Crit Care Med       Date:  2005-01-18       Impact factor: 21.405

Review 6.  Manipulation of immunity to and pathology of respiratory infections.

Authors:  Robert Snelgrove; Andrew Williams; Callum Thorpe; Tracy Hussell
Journal:  Expert Rev Anti Infect Ther       Date:  2004-06       Impact factor: 5.091

7.  Understanding influenza backward.

Authors:  David M Morens; Jeffery K Taubenberger
Journal:  JAMA       Date:  2009-08-12       Impact factor: 56.272

8.  Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift.

Authors:  Matthew J Memoli; Brett W Jagger; Vivien G Dugan; Li Qi; Jadon P Jackson; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

9.  The evolutionary genetics and emergence of avian influenza viruses in wild birds.

Authors:  Vivien G Dugan; Rubing Chen; David J Spiro; Naomi Sengamalay; Jennifer Zaborsky; Elodie Ghedin; Jacqueline Nolting; David E Swayne; Jonathan A Runstadler; George M Happ; Dennis A Senne; Ruixue Wang; Richard D Slemons; Edward C Holmes; Jeffery K Taubenberger
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

10.  Re-emergence of fatal human influenza A subtype H5N1 disease.

Authors:  J S M Peiris; W C Yu; C W Leung; C Y Cheung; W F Ng; J M Nicholls; T K Ng; K H Chan; S T Lai; W L Lim; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

View more
  50 in total

1.  Ferretting out the facts behind the H5N1 controversy.

Authors:  Roy D Sleator
Journal:  Bioeng Bugs       Date:  2012-05-01

2.  Influenza in the 21st century: a call for papers.

Authors:  Tim Nguyen; Adrienne Rashford; Charles R Penn
Journal:  Bull World Health Organ       Date:  2011-05-01       Impact factor: 9.408

Review 3.  The influenza pandemic of 2009: lessons and implications.

Authors:  Paul Shapshak; Francesco Chiappelli; Charurut Somboonwit; John Sinnott
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

4.  Quantitative and qualitative analysis of the influence of confinement by COVID-19 in fracture patients entered in a traumatology service at a third level hospital.

Authors:  D González-Martín; J Álvarez-De la Cruz; P Martín-Vélez; J Boluda-Mengod; J L Pais-Brito; M Herrera-Pérez
Journal:  Rev Esp Cir Ortop Traumatol (Engl Ed)       Date:  2020-12-11

5.  SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues.

Authors:  Tracey Baas; Jeffery K Taubenberger; Pek Yoon Chong; Paul Chui; Michael G Katze
Journal:  J Interferon Cytokine Res       Date:  2006-05       Impact factor: 2.607

6.  N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses.

Authors:  Xiangjie Sun; Akila Jayaraman; Pavithra Maniprasad; Rahul Raman; Katherine V Houser; Claudia Pappas; Hui Zeng; Ram Sasisekharan; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

7.  Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein.

Authors:  Kris M White; Pablo Abreu; Hui Wang; Paul D De Jesus; Balaji Manicassamy; Adolfo García-Sastre; Sumit K Chanda; Robert J DeVita; Megan L Shaw
Journal:  ACS Infect Dis       Date:  2018-01-04       Impact factor: 5.084

8.  Genome rearrangement of influenza virus for anti-viral drug screening.

Authors:  Troy C Sutton; Adebimpe Obadan; Johanna Lavigne; Hongjun Chen; Weizhong Li; Daniel R Perez
Journal:  Virus Res       Date:  2014-05-12       Impact factor: 3.303

9.  Disposable Autonomous Device for Swab-to-Result Diagnosis of Influenza.

Authors:  Shichu Huang; Koji Abe; Steven Bennett; Tinny Liang; Paula D Ladd; Lindsay Yokobe; Caitlin E Anderson; Kamal Shah; Josh Bishop; Mike Purfield; Peter C Kauffman; Sai Paul; AnneMarie E Welch; Bonnie Strelitz; Kristin Follmer; Kelsey Pullar; Luis Sanchez-Erebia; Emily Gerth-Guyette; Gonzalo Domingo; Eileen Klein; Janet A Englund; Elain Fu; Paul Yager
Journal:  Anal Chem       Date:  2017-05-08       Impact factor: 6.986

10.  [Quantitative and qualitative analysis of the influence of confinement by COVID-19 in fracture patients entered in a traumatology service at a third level hospital].

Authors:  D González-Martín; J Álvarez-De la Cruz; P Martín-Vélez; J Boluda-Mengod; J L Pais-Brito; M Herrera-Pérez
Journal:  Rev Esp Cir Ortop Traumatol       Date:  2020-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.